search
Back to results

Heart Cycle Prestudy (PreGEx)

Primary Purpose

Coronary Artery Disease, Acute Myocardial Infarction

Status
Completed
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
Guided Exercise (GEx) system
Sponsored by
RWTH Aachen University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Coronary Artery Disease focused on measuring Coronary Artery Disease, Guided Exercise System including ECG Vest with vital signs sensors and PDA, Validation Telemedical Device in regard to accuracy and safety of data, Homely Rehabilitation, Practicability and technical problems at home

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients suffering from CAD and presenting after an acute myocardial infarction or elective coronary intervention
  • Patients willing to exercise
  • With a preference for walking/ cycling/ running
  • Eligible for the normal local rehabilitation program
  • Contractually capable and mentally able to understand and follow the instructions of the study personnel
  • Able to give informed consent

Exclusion Criteria:

  • Ejection Fraction at discharge from hospital < 30%
  • Unwillingness or lack of capability to handle the device
  • Unable to perform exercise
  • Severe congestive heart failure NYHA III/IV
  • Severe valve disease without replacement
  • Slow healing wounds
  • Women who are pregnant or breastfeeding
  • Refusal of device

Sites / Locations

  • Medical Clinic I, University Hospital Aachen

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

GEx Training

Arm Description

CAD Patients in cardiac rehabilitation phase II (inpatient) and phase III (at home)in order to analyze data for quality of heart rate measurement and data acquisition by device as well as for practicability and technical problems at home.

Outcomes

Primary Outcome Measures

Evaluation of accuracy and safety of data of the GEx system received during in-patient cardiac rehabilitation (phase II) and evaluation of practicability and technical problems in real- life use during cardiac rehabilitation at home (phase III).
The GEx system is evaluated during in-patient cardiac rehabilitation supervised by cardiologists in order to analyze data for quality of heart rate measurement and data acquisition by device. 30 Patients undergo moderate training exercise like walking, cycling or running three times a week three weeks long. In a second step practicability and technical problems are tested during continuation of the moderate training of the patient at home. The Evaluation is performed by CPX, lactate measurement, 2D-Echo, questionnaires and device data like heart rate and breathing rate.

Secondary Outcome Measures

Full Information

First Posted
June 21, 2012
Last Updated
November 26, 2013
Sponsor
RWTH Aachen University
search

1. Study Identification

Unique Protocol Identification Number
NCT01627457
Brief Title
Heart Cycle Prestudy
Acronym
PreGEx
Official Title
Heart Cycle Prestudy Guided Exercise (GEx) for Coronary Artery Disease Patients (CAD) "GEx Home Application Testing"
Study Type
Interventional

2. Study Status

Record Verification Date
November 2013
Overall Recruitment Status
Completed
Study Start Date
September 2011 (undefined)
Primary Completion Date
February 2012 (Actual)
Study Completion Date
February 2012 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
RWTH Aachen University

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
In this Prestudy which will be followed by the multicentral GEx- main-trial, the feasibility of a new cardiac rehabilitation device (GEx system) is proved with coronary heart disease patients who participate in cardiac rehabilitation training exercise at the rehabilitation clinic (phase II) and subsequently at home (phase III). The GEx system consists of a easy-to-wear vest with integrated electrodes to measure electrocardiogram (ECG), respiration and activity, furthermore of a PDA to collect and store the monitored data and a cradle to charge the batteries. Several physiological parameters are extracted from thes measured vital signs like heart rate, breathing rate, ECG and activity. In this pretrial first the GEx sensor system is validated during guided exercise of the patients in the rehabilitation clinic (phase II). Subsequently at home (phase III) the practicability of the vest and sensors and possible technical problems in real- life use are proved. This means after moderate training like walking, cycling or running at home for 3 weeks patients will report the feasibility of usage. The ECG data and breathing- frequency data will be analyzed to see if data are recorded and transmitted well in regard to technical problems.
Detailed Description
During the rehabilitation process (phase II) of patients with coronary heart disease (CAD) 30 patients are recruited and are made familiar with the new Guided Exercise (GEx) training system during exercise training; they are supervised and provided with training instructions by a medicine for 3 times a week 3 weeks long. At the beginning and at the end of the study the patient has to undergo several tests of the clinical routine such as a cardiopulmonary test (CPX), echocardiography and lactate measurement;additionally, this test will be registered by the system to obtain information about the detection of heart rate rise for example. Data will be analyzed for quality of heart rate measurement and data acquisition by the device. In a second step the GEx system is handed to these 30 patients when they leave in-patient cardiac rehabilitation (CR). The pre-trial serves to gather information about the practicability and technical problem during real-life use. Therefore at home these 30 patients will continue with moderate endurance training like walking, cycling or running while wearing the GEx system three times a week for 3 weeks. After three weeks patients will come back to the clinic to undergo the end examination and to report the feasibility of usage. The ECG data and breathing frequency data will be analyzed to see if data are recorded and transmitted well in regard to technical problems. If accurate and safe data are received the following GEx- main- trial (ID 11-020) will investigate the GEx- system for CAD patients in regard to improvement of physical capacities obtained in long term adherence to home based rehabilitation programs (phase III) including feedback to patients compared to national standard rehabilitation.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Coronary Artery Disease, Acute Myocardial Infarction
Keywords
Coronary Artery Disease, Guided Exercise System including ECG Vest with vital signs sensors and PDA, Validation Telemedical Device in regard to accuracy and safety of data, Homely Rehabilitation, Practicability and technical problems at home

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
50 (Actual)

8. Arms, Groups, and Interventions

Arm Title
GEx Training
Arm Type
Experimental
Arm Description
CAD Patients in cardiac rehabilitation phase II (inpatient) and phase III (at home)in order to analyze data for quality of heart rate measurement and data acquisition by device as well as for practicability and technical problems at home.
Intervention Type
Device
Intervention Name(s)
Guided Exercise (GEx) system
Intervention Description
30 CAD patients will wear the GEx system while they are trained during inpatient cardiac rehabilitation (phase II) in order to evaluate accuracy and safety of data like heart rate, breathing, ECG three times a week for about three weeks. In a second step these patients train at home (phase III) in order to evaluate practicability and technical problems of the GEx device three times a week for about three weeks.
Primary Outcome Measure Information:
Title
Evaluation of accuracy and safety of data of the GEx system received during in-patient cardiac rehabilitation (phase II) and evaluation of practicability and technical problems in real- life use during cardiac rehabilitation at home (phase III).
Description
The GEx system is evaluated during in-patient cardiac rehabilitation supervised by cardiologists in order to analyze data for quality of heart rate measurement and data acquisition by device. 30 Patients undergo moderate training exercise like walking, cycling or running three times a week three weeks long. In a second step practicability and technical problems are tested during continuation of the moderate training of the patient at home. The Evaluation is performed by CPX, lactate measurement, 2D-Echo, questionnaires and device data like heart rate and breathing rate.
Time Frame
6 Months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients suffering from CAD and presenting after an acute myocardial infarction or elective coronary intervention Patients willing to exercise With a preference for walking/ cycling/ running Eligible for the normal local rehabilitation program Contractually capable and mentally able to understand and follow the instructions of the study personnel Able to give informed consent Exclusion Criteria: Ejection Fraction at discharge from hospital < 30% Unwillingness or lack of capability to handle the device Unable to perform exercise Severe congestive heart failure NYHA III/IV Severe valve disease without replacement Slow healing wounds Women who are pregnant or breastfeeding Refusal of device
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Patrick Schauerte, Professor MD
Organizational Affiliation
University Hospital Aachen, Department of Cardiology
Official's Role
Principal Investigator
Facility Information:
Facility Name
Medical Clinic I, University Hospital Aachen
City
Aachen
State/Province
North Rhine Westphalia
ZIP/Postal Code
52074
Country
Germany

12. IPD Sharing Statement

Learn more about this trial

Heart Cycle Prestudy

We'll reach out to this number within 24 hrs